Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 237

1.

Older patients are significantly more likely to have colon ischaemia-associated conditions that are chronic and complex.

Silverman M, Aroniadis OC, Feuerstadt P, Fenster M, Huisman T, Mansoor MS, Bhutta AQ, Brandt LJ.

Aliment Pharmacol Ther. 2019 Apr 24. doi: 10.1111/apt.15268. [Epub ahead of print]

PMID:
31020678
2.

Review article: the pharmacological causes of colon ischaemia.

Vodusek Z, Feuerstadt P, Brandt LJ.

Aliment Pharmacol Ther. 2019 Jan;49(1):51-63. doi: 10.1111/apt.15052. Epub 2018 Nov 22. Review.

PMID:
30467871
3.

MELD is the only predictor of short-term mortality in cirrhotic patients with C. difficile infection.

Hong SJ, Feuerstadt P, Brandt LJ.

Dig Liver Dis. 2019 Feb;51(2):275-280. doi: 10.1016/j.dld.2018.07.032. Epub 2018 Aug 1.

PMID:
30172651
4.

Real-world multicentre experience of the pathological features of colonic ischaemia and their relationship to symptom duration, disease distribution and clinical outcome.

Fenster M, Feuerstadt P, Brandt LJ, Mansoor MS, Huisman T, Aroniadis OC.

Colorectal Dis. 2018 Dec;20(12):1132-1141. doi: 10.1111/codi.14323. Epub 2018 Jul 20.

PMID:
29969179
5.

Terminology for vascular lesions of the GI tract.

Brandt LJ.

Gastrointest Endosc. 2018 Jun;87(6):1595-1596. doi: 10.1016/j.gie.2018.01.007. No abstract available.

PMID:
29759167
6.

Thoughts on time constraints and bedside skills.

Rogers AI, Brandt LJ, Meyer GW.

Am J Gastroenterol. 2018 Jun;113(6):789-790. doi: 10.1038/s41395-018-0004-0. Epub 2018 Mar 16. No abstract available.

PMID:
29549358
7.

Fecal Microbiota Therapy With a Focus on Clostridium difficile Infection.

Brandt LJ.

Psychosom Med. 2017 Oct;79(8):868-873. doi: 10.1097/PSY.0000000000000511. Review.

PMID:
28976455
8.

Postinfection Irritable Bowel Syndrome: The Links Between Gastroenteritis, Inflammation, the Microbiome, and Functional Disease.

Downs IA, Aroniadis OC, Kelly L, Brandt LJ.

J Clin Gastroenterol. 2017 Nov/Dec;51(10):869-877. doi: 10.1097/MCG.0000000000000924. Review.

PMID:
28885302
9.

Metastatic adnexal cancer in a man.

Advani R, Izzy M, Akki A, Levine C, Panarelli N, Brandt LJ.

Ann Gastroenterol. 2017;30(5):581-582. doi: 10.20524/aog.2017.0156. Epub 2017 May 12.

10.

Faecal microbiota transplantation: past, present and future.

Brandt LJ.

Med J Aust. 2017 Aug 21;207(4):151-152. No abstract available.

PMID:
28814214
11.

Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.

Staley C, Kelly CR, Brandt LJ, Khoruts A, Sadowsky MJ.

MBio. 2016 Dec 20;7(6). pii: e01965-16. doi: 10.1128/mBio.01965-16.

12.

Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.

Kelly CR, Khoruts A, Staley C, Sadowsky MJ, Abd M, Alani M, Bakow B, Curran P, McKenney J, Tisch A, Reinert SE, Machan JT, Brandt LJ.

Ann Intern Med. 2016 Nov 1;165(9):609-616. doi: 10.7326/M16-0271. Epub 2016 Aug 23.

13.

Beyond Low Flow: How I Manage Ischemic Colitis.

Brandt LJ, Feuerstadt P.

Am J Gastroenterol. 2016 Dec;111(12):1672-1674. doi: 10.1038/ajg.2016.456. Epub 2016 Oct 11. No abstract available.

PMID:
27725651
14.

"We Are Now Free to Speak": Qualitative Evaluation of an Education and Empowerment Training for HIV Patients in Namibia.

MacLachlan EW, Potter K, Hamunime N, Shepard-Perry MG, Uusiku J, Simwanza R, Brandt LJ, O'Malley G.

PLoS One. 2016 Apr 7;11(4):e0153042. doi: 10.1371/journal.pone.0153042. eCollection 2016.

15.

Reply.

Feuerstadt P, Aroniadis OA, Brandt LJ.

Clin Gastroenterol Hepatol. 2016 May;14(5):780-1. doi: 10.1016/j.cgh.2016.02.003. Epub 2016 Feb 4. No abstract available.

PMID:
26853159
16.

Evaluating the effectiveness of patient education and empowerment to improve patient-provider interactions in antiretroviral therapy clinics in Namibia.

Maclachlan EW, Shepard-Perry MG, Ingo P, Uusiku J, Mushimba R, Simwanza R, Likoro J, Brandt LJ, Thomas KK, Kasonka C, Hamunime N, O'Malley G.

AIDS Care. 2016;28(5):620-7. doi: 10.1080/09540121.2015.1124975. Epub 2015 Dec 23.

17.

On the prevalence and utility of IBD-immune markers in colon ischemia.

Brandt LJ, Aroniadis OC, Feuerstadt P.

Am J Gastroenterol. 2015 Oct;110(10):1507. doi: 10.1038/ajg.2015.290. No abstract available.

PMID:
26465911
18.

Recommendations for Probiotic Use--2015 Update: Proceedings and Consensus Opinion.

Floch MH, Walker WA, Sanders ME, Nieuwdorp M, Kim AS, Brenner DA, Qamar AA, Miloh TA, Guarino A, Guslandi M, Dieleman LA, Ringel Y, Quigley EM, Brandt LJ.

J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1:S69-73. doi: 10.1097/MCG.0000000000000420. Erratum in: J Clin Gastroenterol. 2016 Oct;50(9):800.

PMID:
26447969
19.

Fecal Microbiota Transplant: Respice, Adspice, Prospice.

Brandt LJ.

J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1:S65-8. doi: 10.1097/MCG.0000000000000346. Review.

PMID:
26447968
20.

Update on Colon Ischemia: Recent Insights and Advances.

Feuerstadt P, Brandt LJ.

Curr Gastroenterol Rep. 2015 Dec;17(12):45. doi: 10.1007/s11894-015-0469-6. Review.

PMID:
26446556

Supplemental Content

Loading ...
Support Center